F.L. Putnam Investment Management’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $424K | Buy |
6,136
+1,070
| +21% | +$73.9K | 0.01% | 441 |
|
|
2025
Q1 | $352K | Sell |
5,066
-629
| -11% | -$43.7K | 0.01% | 467 |
|
|
2024
Q4 | $490K | Sell |
5,695
-897
| -14% | -$77.2K | 0.01% | 421 |
|
|
2024
Q3 | $785K | Buy |
6,592
+1,391
| +27% | +$166K | 0.01% | 358 |
|
|
2024
Q2 | $742K | Buy |
5,201
+283
| +6% | +$40.4K | 0.01% | 362 |
|
|
2024
Q1 | $631K | Buy |
4,918
+8
| +0.2% | +$1.03K | 0.01% | 309 |
|
|
2023
Q4 | $508K | Sell |
4,910
-235
| -5% | -$24.3K | 0.01% | 332 |
|
|
2023
Q3 | $468K | Buy |
5,145
+1
| +0% | +$91 | 0.01% | 345 |
|
|
2023
Q2 | $416K | Buy |
5,144
+414
| +9% | +$33.5K | 0.01% | 375 |
|
|
2023
Q1 | $376K | Buy |
4,730
+682
| +17% | +$54.3K | 0.01% | 338 |
|
|
2022
Q4 | $274K | Buy |
+4,048
| New | +$274K | 0.01% | 355 |
|
|
2022
Q2 | – | Sell |
-4,038
| Closed | -$224K | – | 419 |
|
|
2022
Q1 | $224K | Sell |
4,038
-1,534
| -28% | -$85.1K | 0.01% | 382 |
|
|
2021
Q4 | $312K | Hold |
5,572
| – | – | 0.01% | 332 |
|
|
2021
Q3 | $267K | Sell |
5,572
-130
| -2% | -$6.23K | 0.01% | 346 |
|
|
2021
Q2 | $239K | Buy |
+5,702
| New | +$239K | 0.01% | 374 |
|
|
2020
Q4 | – | Sell |
-5,858
| Closed | -$203K | – | 332 |
|
|
2020
Q3 | $203K | Buy |
+5,858
| New | +$203K | 0.01% | 292 |
|